- Report
- October 2024
- 183 Pages
Global
From €3238EUR$3,545USD£2,762GBP
€3598EUR$3,939USD£3,068GBP
- Report
- October 2024
- 194 Pages
Global
From €3238EUR$3,545USD£2,762GBP
€3598EUR$3,939USD£3,068GBP
- Report
- March 2025
- 145 Pages
Global
From €2740EUR$2,999USD£2,336GBP
- Report
- April 2025
- 200 Pages
Global
From €2275EUR$2,490USD£1,940GBP
- Report
- March 2025
- 200 Pages
Global
From €4102EUR$4,490USD£3,498GBP
- Report
- January 2025
- 200 Pages
Global
From €4102EUR$4,490USD£3,498GBP
- Report
- May 2025
- 174 Pages
Global
From €5344EUR$5,850USD£4,557GBP
- Report
- May 2025
- 297 Pages
Global
From €5344EUR$5,850USD£4,557GBP
- Report
- May 2025
- 93 Pages
Global
From €5344EUR$5,850USD£4,557GBP
- Report
- May 2025
- 182 Pages
Global
From €5344EUR$5,850USD£4,557GBP
- Report
- March 2025
- 150 Pages
Global
From €4430EUR$4,850USD£3,778GBP
- Report
- July 2024
- 156 Pages
Global
From €3300EUR$3,613USD£2,814GBP
€3882EUR$4,250USD£3,311GBP
- Report
- February 2024
- 111 Pages
Global
From €4339EUR$4,750USD£3,700GBP
- Report
- October 2023
- 140 Pages
Global
From €3288EUR$3,599USD£2,804GBP
- Report
- June 2022
- 74 Pages
North America
From €1370EUR$1,500USD£1,168GBP
- Report
- June 2022
- 82 Pages
Middle East, Africa
From €1370EUR$1,500USD£1,168GBP
- Report
- June 2022
- 82 Pages
Asia Pacific
From €1370EUR$1,500USD£1,168GBP
- Report
- January 2024
- 93 Pages
Global
From €3500EUR$4,104USD£3,089GBP
- Report
- October 2024
- 90 Pages
India
From €1189EUR$1,301USD£1,014GBP
€1698EUR$1,859USD£1,448GBP
- Report
- October 2024
- 110 Pages
North America
From €1562EUR$1,710USD£1,332GBP
€2232EUR$2,443USD£1,903GBP

The Bioprosthetic Valve market is a segment of the Cardiovascular Devices industry. It is composed of medical devices used to replace or repair a patient's heart valve. These valves are made from animal tissue, such as porcine or bovine, and are designed to mimic the natural functioning of the human heart valve. Bioprosthetic valves are used to treat a variety of conditions, including aortic stenosis, mitral regurgitation, and tricuspid regurgitation. They are also used in combination with other treatments, such as coronary artery bypass grafting.
Bioprosthetic valves are becoming increasingly popular due to their durability and low risk of complications. They are also cost-effective and require less maintenance than mechanical valves.
Some of the major companies in the Bioprosthetic Valve market include Edwards Lifesciences, Medtronic, St. Jude Medical, Boston Scientific, and Sorin Group. Show Less Read more